reNEW

Market Access

One area where the Novo Nordisk Foundation has invested quite heavily is in cell therapy, especially stem cell research.

News

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.